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Abstract 
 
PET imaging with gallium-68 (68Ga) has become widely used due to the availability of 
68Ge/68Ga generators and DOTA-derivatised peptide ligands for radiolabelling. The 
purpose of this study was to monitor the eluate of two iThemba LABS 68Ge/68Ga 
generators over a period of 12 months to ascertain whether all quality parameters of 
the 68Ga eluate remained stable and to validate different analytical methods used to 
determine the radiochemical purity of 68Ga-labelled peptides. 
 
Two 1850 MBq (50 mCi) generators were eluted daily with 0.6 M HCl and metal 
contaminants, 68Ge breakthrough, 68Ga yield, pH, sterility and endotoxin 
concentrations were determined on a monthly basis. The radiochemical purity of 
68Ga-labelled peptides was ascertained using high performance liquid 
chromatography (HPLC) and instant thin layer chromatography (iTLC). iTLC 
experiments were performed using both dried and undried iTLC plates. iTLC was 
also carried out on labelled peptide solution that was spiked with 68GaCl3. These 
results were also compared with those using HPLC.  
 
After 12 months the 68Ga yields, total metal contaminants, sterility and endotoxin 
concentration remained within European Pharmacopoeial limits. The 68Ge 
breakthrough increased as the generator aged. This can however be minimised by 
fractionated elution and post-labelling processing of the eluate by anion or cation 
exchange chromatography. 
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Separation between 68GaCl3 and 68Ga-labelled peptides was obtained using both 0.1 
M citrate buffer pH 5.0 (mobile phase 1) and 1 M ammonium acetate : methanol (1:1) 
(mobile phase 2). The results also showed that the distribution of radioactivity on the 
iTLC strip could be determined using a dose calibrator when a TLC scanner is not 
available. Experiments performed using both undried and dried iTLC-SG 
chromatography paper, demonstrated that despite the statistically significant 
difference between the sets of results, in practice either undried or dried iTLC may be 
used. When purified 68Ga-labelled peptides were spiked with 2% of 68GaCl3, 
separation between the two was obtained on both HPLC and iTLC. However, iTLC 
underestimated and HPLC overestimated 68GaCl3 content. Of the two iTLC methods 
investigated, the method using mobile phase 2 was able to separate colloidal 68Ga 
impurities from the 68Ga-labelled peptides while the method using mobile phase 1 
and the HPLC method could not. 
 
In conclusion, the iThemba LABS 68Ge/68Ga generator can be considered stable and 
of use for up to one year after its manufacture. Both the iTLC method and the HPLC 
method could detect 68GaCl3 amounts less than 2%. The pharmacopoeia states that 
68Ga must be less than 3 % on iTLC and less than 2 % on HPLC. Either dried or 
undried iTLC strips can be used and if a radio-TLC scanner is not available, the iTLC 
strips developed with mobile phase 1 can be cut at a suitable distance from the origin 
and the activity on each section can be read in a dose calibrator. iTLC 
chromatography using ammonium acetate/methanol seems to be the optimal system 
for routine analysis of 68Ga labelled DOTA-peptides, as it separates both 68GaCl3 and 
colloidal impurities from the labelled peptides and is a fast and easy technique. 
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Opsomming 
 
PET beelding met gallium-68 (68Ga) word deesdae algemeen aangewend as gevolg 
van die beskikbaarheid van 68Ge/68Ga generators en DOTA-afgeleide peptied ligande 
vir radiomerking. Die doelstelling van hierdie studie was om die eluate van twee 
iThemba LABS 68Ge/68Ga generators oor ‘n 12 maande periode te moniteer om vas 
te stel of al die gehalteparameters van die 68Ga eluaat stabiel bly. ‘n Verdere 
doelstelling was om verskillende analitiese metodes vir bepaling van die 
radiochemiese suiwerheid van 68Ga-gemerkte peptiede te bekragtig. 
 
Twee 1850 MBq (50 mCi) generators is daagliks met 0.6M HCl ge-elueer en 
bepalings van metaalonsuiwerhede, 68Ge deurbraak, 68Ga opbrengste, pH, steriliteit 
en endotoksien konsentrasie is maandeliks herhaal. Die radiochemiese suiwerhede 
van 68Ga-gemerkte peptiede is met behulp van hoȅdoeltreffendheid- 
vloeistofchromatografie (HDVC) en kits dunlaag chromatografie of sg. instant thin 
layer chromatography (iTLC) bepaal. iTLC eksperimente is uitgevoer met beide 
gedroogde en ongedroogde iTLC papier. iTLC is ook uitgevoer op gemerkte peptied 
monsters wat doelbewus met klein hoeveelhede 68GaCl3 gekontamineer is. Hierdie 
resultate is vergelyk met HDVC resultate van dieselfde monsters. 
 
Die 68Ga opbrengste, totale metaalonsuiwerhede, steriliteit en endotoksien 
konsentrasie het na ‘n periode van 12 maande binne die grense van die Europese 
Farmakopee gebly. Die 68Ge deurbraak het toegeneem met veroudering van die 
generator maar dit kan beperk word deur gefraksioneerde eluering of prosessering 
van die eluaat met behulp van anioon- of katioon-uitruilchromatografie. 
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Skeiding tussen 68GaCl3 en 68Ga-gemerkte peptiede is verkry met die gebruik van 
beide 0.1 M sitraat buffer pH 5 (mobiele fase 1) en 1 M ammonium asetaat : metanol 
(1:1) (mobiele fase 2). Die resultate het getoon dat die verspreiding van 
radioaktiwiteit op ‘n iTLC strook met behulp van ‘n dosiskalibreerder bepaal kan word 
wanneer ‘n TLC skandeerder nie beskikbaar is nie. Die eksperimente met vooraf 
gedroogde sowel as ongedroogde iTLC strokies het getoon dat, ten spyte van 
statisties betekenisvolle verskille tussen die resultate, beide in praktyk gebruik kan 
word. In gevalle waar gesuiwerde 68Ga-gemerkte peptiede doelbewus gekontamineer 
is met 2% 68GaCl3, is skeiding tussen die twee spesies verkry in beide HDVC en 
iTLC analises. 68GaCl3 inhoud is egter onderskat met iTLC en oorskat met HDVC. 
Die metode waarin mobiele fase 2 gebruik is, was in staat om kolloïdale 68Ga 
onsuiwerhede te skei van die 68Ga-gemerkte peptiede, terwyl mobiele fase 1 en die 
HDVC metodes dit nie kon doen nie. 
 
Ter samevatting, die iThemba LABS 68Ge/68Ga generator kan as stabiel beskou word 
en vir ‘n periode van tot een jaar na vervaardiging gebruik word. Beide die HDVC en 
iTLC metodes kon 68Ga hoeveelhede van minder as 2% bepaal. Die Europese 
Farmakopee skryf voor dat 68Ga laer as 3 % moet wees met iTLC en laer as 2 % met 
HDVC. Gedroogde of ongedroogde iTLC papier kan gebruik word en indien ‘n iTLC 
radioskandeerder nie beskikbaar is nie, kan iTLC stroke wat met mobiele fase 1 
ontwikkel is, ‘n geskikte afstand  vanaf die oorsrong deurgesny word en die aktiwiteit 
op elke deel in ‘n dosiskalibreerder gelees word. iTLC met ammonium 
asetaat/metanol as mobiele fase, blyk die optimale sisteem vir roetine-analise van 
68Ga-gemerkte peptiede te wees, omdat dit beide 68GaCl3 en kolloïdale 68Ga 
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onsuiwerhede van die gemerkte peptiede kan skei en ook ‘n vinnige en maklike 
tegniek is. 
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Chapter 1: Introduction 
 
Over the past twenty years, Positron Emission Tomography (PET) has become an 
accepted tool for diagnosing disease. [1] The limitations of fluorine-18 
fluorodeoxyglucose (18F-FDG), which has been widely used for PET applications, 
prompted the development of new PET radiopharmaceuticals such as those 
labelled with gallium-68 (68Ga) [2]. 68Ga-labelled radiopharmaceuticals have 
proved to be significant and relevant as PET tracers for the detection and 
management of certain tumours, including neuroendocrine tumours [2]. 68Ga is 
obtained from 68Ge/68Ga generators, which have been available since the 
beginning of the twenty first century. The recent development of a number of 
peptide ligands has resulted in the increased use of the 68Ge/68Ga generator [2]. 
 
There are five different generators on the market [3, 4]. The columns of these 
generators are either titanium dioxide (TiO2), tin dioxide (SnO2) or organic resin 
based. For clinical applications, the eluates of these generators have to be of 
medicinal quality i.e. low germanium-68 (68Ge) breakthrough, low metal ion 
content and sterile and apyrogenic. A narrow elution profile is essential as it gives 
the most activity in the smallest volume of eluate. These properties must remain 
stable for the shelf life of the generator [3]. In addition, 68Ga-labelled peptides 
should also comply with the necessary quality requirements such as radiochemical 
purity, in order to be suitable for use as radiopharmaceuticals [2]. Radiochemically 
impure labelled peptides, such as those that are contaminated with free gallium-68 
(68Ga), could result in low quality PET images and increase radiation exposure of 
patients.  
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The aims of this research study are to evaluate the 68Ga eluate obtained from the 
iThemba LABS tin dioxide-based 68Ge/68Ga generator over a period of twelve 
months in order to ascertain whether the quality of the eluate remains stable, and 
to validate the quality control methods currently published in literature and used in 
radiopharmaceutical laboratories all over the world to determine the radiochemical 
purity of 68Ga-labelled DOTA peptides. 
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Chapter 2: Literature Review and Problem Statement 
 
LITERATURE REVIEW 
2.1 PET Radiopharmaceuticals 
Since the introduction of PET, 18F-FDG has been a work-horse of major PET 
facilities across the globe. FDG is a glucose analogue that is taken up by cells that 
have a high metabolic turnover and is therefore useful for detecting malignant 
tumours. It is commonly used in staging, re-staging, assessing response to 
therapy and in regular follow up of oncology patients. However, 18F-FDG does 
have limitations including [1]: 
 Some highly differentiated cancers, including prostate carcinoma, have a 
low growth rate and may therefore not be suitable for 18F-FDG scans; 
 With 18F-FDG it may be difficult to evaluate lesions in or close to tissues 
that normally show high FDG concentrations due to metabolism of the 
radiopharmaceutical  e.g. brain or bladder; and 
 18F-FDG is not specific for malignancies, as it also accumulates in infective 
or inflammatory lesions.  
These shortcomings triggered the development of many new positron emitting 
radiopharmaceuticals. 68Ga-labelled peptides such as somatostatin analogues, 
minigastrin, bombesin and RGD-based peptides, offer a solution to these 
shortcomings with the combined advantage of the short half-life (that is 
nevertheless long enough to allow chemical manipulations) and availability of 68Ga 
from a 68Ge/68Ga generator [2]. 
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2.2 68Ge/68Ga Generator 
A radionuclide generator consists of a system containing a parent radionuclide 
which decays to a daughter isotope with a shorter half-life. The daughter isotope 
can be eluted while the parent is retained. In the case of the 68Ge/68Ga generator, 
the parent radionuclide 68Ge is in equilibrium with the daughter radionuclide 68Ga. 
The generator provides a constant source of 68Ga which, because of its short half-
life, cannot be shipped over long distances. [3]. An ideal generator system has the 
following properties: 
1. The eluate must be sterile and pyrogen free for clinical applications. 
2. The daughter radionuclide (in this case 68Ga) must differ chemically 
from the parent radionuclide (68Ge) to enable separation by means of 
chromatography. 
3. No aggressive chemical reactions should be required to retrieve the 
daughter radionuclide from the generator system. 
4. The elution process should be very simple, with limited manipulation of 
radioactivity in order to protect the operator from excessive radiation 
exposure. 
5. For diagnostic imaging the daughter radionuclide should be a gamma 
photon or positron emitter with a short half-life. 
6. The parent radionuclide should have a sufficiently short physical half-life 
to allow fast re-growth of the daughter radionuclide after elution. At the 
same time, the half-life of the parent radionuclide must be sufficiently 
long to allow time for transport and to provide a long generator usage 
time. 
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7. The properties of the daughter radionuclide should be such that it can 
be used to prepare a range of radiolabelled compounds. 
8. The daughter radionuclide should decay to a stable “granddaughter” to 
minimize exposure of patients, staff or the public. 
9. To reduce radiation exposure of users of the generator, it should be 
contained in suitable shielding [3]. 
 
2.2.1 History of the 68Ge/68Ga Generator 
The 68Ge/68Ga generator was first described by Gleason in 1960 [5]. He made 
reference to a “positron cow” where the daughter radionuclide with a shorter half-
life would be available when needed while the parent radionuclide with the longer 
half-life was retained for “growth” of the daughter radionuclide. Gleason employed 
a solvent-extraction method with acetylacetone in cyclohexane for the separation 
of 68Ga from 68Ge. 
 
In 1961 Green and Tucker [6] introduced a solid phase ion exchange extraction 
method for the separation of 68Ga from 68Ge. The generator comprised an Al2O3 
support and was eluted with ethylenediaminetetraacetic acid (EDTA). 
 
In 1964, Yano and Anger [7] described a generator with an alumina column that 
was eluted with 0.005 M EDTA. The 68Ga-EDTA eluate could be used directly for 
clinical patient imaging, e.g. for localisation of brain tumours. The development of 
new radiopharmaceuticals, however, was prevented due to the complicated 
chemistry that was required to break down the stable 68Ga-EDTA complex. 
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In 1979 Loch et al [8] developed a 68Ge/68Ga generator as a source of ionic 68Ga. 
The generator consisted of a tin dioxide column and it was eluted with hydrochloric 
acid (HCl). The tin dioxide generator provided a sterile solution of 68Ga in ionic 
form, ready for use in the preparation of many radiopharmaceuticals. Other ionic 
generators have Al(OH)3, Fe(OH)3, iron oxide, ZrO2, TiO2 and CeO2 supports [3]. 
 
In 1981 Schumacher and Maier-Borst [9] prepared a generator using an ion 
exchange resin composed of pyrogallol and formaldehyde. The 68Ga was easily 
eluted with HCl. Nakayama et al reported in 2003 that a styrene-divinyl-benzene 
copolymer, containing N-methylglucamine, was a suitable support for 68Ge from 
which 68Ga can be eluted with citric acid or phosphoric acid [10]. 
 
2.2.2 Current 68Ge/68Ga Generators 
The generators that are currently on the market are either titanium dioxide (TiO2), 
tin dioxide (SnO2) or organic resin based. The TiO2 based generators are 
manufactured by Cyclotron Ltd, Obninsk, Russia and Eckert and Ziegler, 
Germany. iThemba LABS in South Africa produces a SnO2 based generator 
system. To prepare this generator, a gallium suboxide (GaO2) target is bombarded 
with protons to produce the parent radionuclide 68Ge via the nuclear reaction 
69Ga(p,2n)68Ge. The 68Ge is then radiochemically separated from the Ga target by 
solvent extraction and loaded onto a column composed of a calcified SnO2 resin 
[11]. A SiO2/organic (organic matrix on a silica resin) generator which is eluted with 
0.05 N HCl, is available from Isotope Technologies Garching (ITG) [3]. A fifth 
generator, Galli Eo is produced by IRE ELiT (the column material is not specified) 
[4]. The column matrices and eluents of the different 68Ge/68Ga generators are 
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summarised in Table 1. An overview of the properties of the generators that are 
commercially available is presented in Table 2. The TiO2 generator from Cyclotron 
Ltd, Obninsk, Russia has an initial 68Ga yield of approximately 80 % with a 68Ge 
breakthrough of approximately 1-10-3 %. The 68Ga yield decreases to about 50 % 
and the breakthrough to about 10-2 % after 200 elutions. The elution 
characteristics of the Eckert and Ziegler IGG100 generator are said to surpass that 
of the Cyclotron Ltd generator. The iThemba LABS SnO2 generator has an 
optimum 68Ga elution efficiency with 0.6 M HCl and the elution efficiency of the 
generator was found to decrease to about 50 % after 100 elutions [12]. 
In 2013, Rösch [13] projected that further developments in labelling techniques, 
clinical applications, improvements in resin materials to reduce 68Ge breakthrough, 
new ligands and GMP-certified generators will result in increased use of the 
68Ge/68Ga generators. 
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TABLE 1: Column matrices with corresponding eluents 
(reproduced from Velikyan: 68Ga-based Radiopharmaceuticals: Production and Application 
Relationship [3]) 
68Ge/68Ga Generator Column Matrix and Eluents 
Inorganic 
Matrix Eluents 
SnO2 1 M HCl 
TiO2 0.1 M HCl 
CeO2 0.02 M HCl 
ZrO2 0.1 M HCl 
Zr-Ti ceramic 0.5 M NaOH/KOH; 4 M HCl; acetate; citrate 
Nano-zirconia 0.01 M HCl 
Organic 
Matrix Eluents 
Pyrogallol-formaldehyde 0.3 M HCl 
Nanoceria-polyacrylonitrile 0.1 M HCl 
N-methylglucamine 0.1 M HCl; 0.1 M NaOH; citrate; EDTA 
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TABLE 2: Commercially available generators and their properties 
(reproduced from Velikyan: 68Ga-based Radiopharmaceuticals: Production and Application 
Relationship [3] and producer specifications) 
 
Obninsk Cyclotron 
Co. Ltd. 
(marketed by 
Eckert and 
Ziegler) 
Eckert & Ziegler 
IGG100 
and IGG101 
GMP; 
Pharm. Grade 
I.D.B. Holland 
B.V. 
(iThemba LABS) 
Isotope 
Technologies 
Garching (ITG) 
IRE Elit 
Column matrix  TiO2  TiO2  SnO2  SiO2/organic 
Not 
specified 
Eluent  0.1 M HCl 0.1 M HCl  0.6 M HCl  0.05 M HCl 0.1 M HCl 
68Ga Yield 
not < 75 % for 
each elution 
Greater than 60 
% of nominal 
activity 
Not less than 80 
% 
at calibration time 
Greater than 
80 % on 
calibration 
date 
70 – 75 % 
and ≥ 60 % 
after 12 
months 
68Ge 
breakthrough 
<0.005 % after 
400 elutions 
<0.001 % 
< 0.001 % 
at calibration time 
<0.005 % ≤ 0.001 % 
Eluate volume 5 ml 5 ml 6 ml 4 ml 1.1 ml 
Chemical 
impurity  
Ga: <1 µg/37 MBq 
Ni < 1µg/37 MBq 
Fe: <10 µg/GBq 
Zn: <10 µg/GBq 
<10 ppm  
(Zn, Sn, Fe, Al,) 
Only Zn from 
decay 
Fe, Cu, Ga, 
Ni, Pb, Zn ≤ 
10 µg/GBq 
individually 
Weight 11.7 kg 10 kg and 14 kg 26 kg 16 kg 
Not 
specified 
 
2.2.3 Studies performed to evaluate the eluate of 68Ge/68Ga generators 
The following studies were performed to evaluate the generator: 
 In 1984, McElvany et al. [14] compared the elution profiles, yields, 
germanium breakthrough and metal contaminants of three different 
generator types over a period of one year. The generators were an 
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alumina/0.005 M EDTA 68Ge/68Ga generator, an alumina 0.1 M NaOH 
68Ge/68Ga generator and a tin dioxide/1 M HCl 68Ge/68Ga generator. 
Elution yields were measured daily for one year. Eluates were measured 
immediately after elution and again after 24 to 48 hours using a NaI(Tl) 
scintillation detector to determine 68Ge breakthrough. Metal contaminants 
were determined by means of emission spectroscopy.  
 In 2008, Asti et al. [15] evaluated the eluates from a titanium dioxide 
generator over a period of 7 months. The generator was eluted 3 times a 
week and approximately 100 elutions were performed. The eluates were 
used to determine 68Ga yield, 68Ge breakthrough and metal contaminants. 
 In 2013, Das et al. [16] published an evaluation of a tin dioxide generator 
over a period of six months. This generator was produced by the Board of 
Radiation and Isotope Technology, India. Random eluates were used to 
monitor elution efficiency, 68Ge breakthrough and 65Zn content. 
 A study was published in 2014 by Sudbrock et al. [17] using four iThemba 
LABS SnO2-based 68Ge/68Ga generators to evaluate the 68Ge breakthrough 
over time. Three of the generators were evaluated over a period of nine 
months while the fourth generator was evaluated over a period of eight 
months. Three samples of eluate were measured repeatedly over a period 
of 7 months to obtain the decay curves. 68Ge breakthrough was determined 
on 123 eluates and 115 68Ga-DOTATATE samples. 
 Ebenhan et al. performed a retrospective analysis to evaluate the effect of 
eluate characteristics on several 68Ga-labelled peptides over a prolonged 
period of generator use, but no data was provided [18]. 
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 In 2016, Amor-Coarasa et al. [19] evaluated the performance of the ITG 
generator over a period of 1 year. The 68Ge breakthrough was <0.006 % at 
the start and decreased to 0.001 %. A decrease in 68Ge breakthrough with 
time is unique to this generator. 
 A study to ascertain whether microorganisms survived in 68Ga eluates and 
after the re-generation of cold columns which had been loaded with 
different microorganisms was performed by Petrik et al. [20]. A titanium 
dioxide generator was used for these experiments and the microorganisms 
used included Staphylococcus aureus, Clostridium sporogenes, 
Helicobactor pylori, Deinococcus radiodurans, Aspergillus niger and 
Candida albicans. 
 
2.2.4 European Pharmacopoeia (Ph Eur) Specifications for 68Ga Eluate 
If the 68Ga eluate is to be used for clinical applications it must meet the Ph Eur 
specifications below [21]: 
Appearance: Clear and colourless 
Radionuclidic identity (half-life determination): 62 to 74 minutes 
Radionuclidic identity (gamma-ray spectrometry): 511 and 1077 keV 
Radionuclidic purity (gamma-ray spectrometry): > 99.9 % 
68Ge breakthrough: < 0.001 % 
Radiochemical purity (TLC): > 95 % 
Microbiological quality: sterile 
Bacterial endotoxins: < 175/V EU/ml* 
                                                          
 
* V = volume to be injected and EU = Endotoxin Units 
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pH: < 2 
Iron: < 10 µg/GBq 
Zinc: < 10 µg/GBq 
 
All the parameters, except the radionuclidic identity, which is confirmed only at the 
start of use of the generator, must be evaluated for the period of use. The pH of 
the eluate is not expected to change unless a different eluent is used. 
 
2.3 Peptide Ligands 
68Ga allows excellent visualization of tumours and small metastases when labelled 
with a suitable ligand. 68Ga can be coupled with peptides including somatostatin 
analogues and prostate specific membrane antigen (PSMA) antibody fragments. 
The 68Ga-labelled somatostatin analogues DOTANOC, DOTATATE and 
DOTATOC (Figure 1) have been used clinically since the 1990’s [22]. The 68Ga-
DOTA-conjugated peptides have a high affinity for somatostatin receptors which 
are over-expressed in neuroendocrine tumours (NETs) and therefore have great 
potential for the imaging of somatostatin receptor-expressing tumours by means of 
PET scans [23]. 
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Figure 1: Structural Formula of DOTATATE, DOTATOC and DOTANOC 
(reproduced from Breeman et al. [24]) 
 
Somatostatin is a small peptide that binds to somatostatin receptors. It is found in 
neurones and endocrine cells, brain, pancreas and gastro-intestinal tract. The 
somatostatin receptors are expressed by many neuroendocrine and non-
neuroendocrine cells of the body. Five different types of human somatostatin 
receptors have been identified and all the receptors are over expressed in 
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neuroendocrine tumours. Because somatostatin has a short biological half-life, 
more stable synthetic analogues have been developed. When radiolabelled with 
68Ga, somatostatin analogues enable in vivo visualisation of these tumours by 
means of somatostatin receptor scintigraphy using PET or SPET scans [23]. The 
molecular structure of the DOTA analogues of somatostatin, i.e. DOTATATE, 
DOTATOC and DOTANOC, enables rapid and efficient binding with 68Ga at high 
specific activities [25]. 
 
Initial patient studies have demonstrated the potential of PET technology using 
68Ga-DOTANOC, 68Ga-DOTATATE and 68Ga-DOTATOC. They are used for 
diagnosis, staging, prognosis, therapy selection and response monitoring of NETs 
and other types of cancers and diseases. The major difference among these 
compounds is the slight difference in affinities to somatostatin subtypes. All tracers 
can bind to sst2 receptors, which is the predominant receptor type in NETs. 
DOTATOC and DOTANOC also bind to sst5 receptors, while only the DOTANOC 
analogue shows good affinity for sst3 receptors [26]. 
 
Tumour types that may be visualised with PET/CT, using 68Ga-DOTA-conjugated 
somatostatin analogues, include gastro-entero-pancreatic tumours and sympatho-
adrenal system tumours as well as several other carcinomas [27]. 
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2.3.1 Chemistry of 68Ga and peptide labelling 
Gallium can exist in oxidation state Ga3+ and Ga1+. 68Ga is eluted with HCl in the 
form of Ga3+, which is the only stable chemical form in aqueous solution. The free 
Ga3+ in acid solution binds with the peptide molecules during the radiolabelling 
reaction. At pH values up to 3, Ga3+ and [Ga(H2O)6]3+ which is soluble, are formed. 
At pH values between 3 and 7, Ga3+ hydrolyses and forms a colloidal precipitate 
i.e. Ga(OH)3. Gallate ions ([Ga(OH)4]-) are formed at pH values greater than 7.4. 
Colloids and gallate ions will not form complexes with peptide molecules and will 
result in low labelling yields. Labelling with 68Ga is therefore pH sensitive and the 
pH of the reaction mixture has to be low to minimise the formation of colloids and 
gallate ions [12]. In a labelling mixture that is buffered with citrate, acetate or 
HEPES, the Ga is in the form of [Ga(H2O)6]3+. In this form the Ga is inhibited from 
being hydrolysed to Ga(OH)3. After radiolabelling it would be possible to find either 
unbound gallium chloride, or hydrolysed insoluble gallium hydroxide in the peptide 
preparation. Gallium chloride is almost entirely bound to transferrin after 
intravenous injection of very small amounts [28], from where it probably slowly 
distributes mostly to bones, lungs, kidney and spleen [29]. Like other colloids, 
insoluble gallium species are expected to accumulate in the liver, spleen and bone 
marrow [30]. Because Ga can exist in different forms, the methods used for 
analysis must be capable of detecting them. According to the European 
Pharmacopeia (Ph Eur) monograph for 68Ga-DOTATATE [21], free 68Ga must be 
less than 3 % on iTLC and less than 2 % on HPLC and not more than 3 % of the 
total radioactivity should be due to 68Ga in colloidal form for TLC analysis. 
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2.3.2 Radiochemical Purity of DOTA-Peptides 
Simple and reliable quality control (QC) analytical methods should be available for 
determining the integrity of the labelled peptides before administration to patients. 
The methods employed are usually high performance liquid chromatography 
(HPLC), which requires more complex equipment and relatively large volumes of 
mobile phases, and instant thin Layer chromatography (iTLC) because of its 
convenience and the short time within which it can be performed. The methods 
used to determine the radiochemical purity of 68Ga-labelled peptides are 
summarized below. 
 
2.3.2.1 TLC Methods 
Di Pierro et al. [23] evaluated the radiochemical purity of 68Ga-DOTANOC by 
means of TLC using two different supports, namely, iTLC-SG and Flash-TLC 
TecControl strips. The TLC results were validated by means of HPLC. The TLC 
mobile phase used for both methods was 0.1 M citrate/0.2 M HCl. No further 
details were provided. 
 
The radiochemical purity of 68Ga-DOTANOC was determined by Asti et al. [15] 
using 0.1 M sodium citrate mobile phase, pH 5 (method 1) and an RP-18F 
support, and by Mukherjee et al. [31, 32] and De Blois [33] et al., on an iTLC 
support. Both Asti and Mukherjee et al found that the Rf of DOTANOC was 0.0 
and of free 68Ga3+ was 0.9. It appears that this method only serves to detect free 
Ga3+. They also used a second method which employed 1 M ammonium 
acetate/methanol (1:1) (method 2) as the mobile phase with an iTLC-SG support. 
For this method, Asti only stated that the Rf of DOTANOC was 0.9 and of 
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hydrolyzed 68Ga was 0.1, without mentioning where free Ga3+ would migrate. This 
suggests that method 2 only serves to detect hydrolysed or colloidal 68Ga, and 
method 1 would still be required to distinguish between labelled peptides and free 
gallium. De Blois et al. used a two strip method but do not comment on distinction 
between different impurities. In comparison, Mukherjee et al. stated that the Rf of 
68Ga-DOTA peptides was found to be 0.9 -1.0 and free Ga (III) and colloidal 68Ga 
were both found to be 0.0 - 0.1 using method 2. This implies that method 2 can be 
used to distinguish the labelled peptides from both impurities, although it does not 
separate the impurities from each other. Mukherjee et al. also used paper 
chromatography (Whatman 3-MM) to determine radiochemical yield. Paper 
chromatography using 50 % aqueous acetonitrile revealed that 68Ga-DOTANOC 
moved towards the solvent front and free Ga (III) and colloidal gallium both 
remained at the origin (Rf = 0.0). Mukherjee’s results show that either of the 
methods can be used. iTLC gives better separation, is faster to run, less sample is 
required, there is better selectivity and different stationery phases can be selected. 
Paper chromatography may have been used because it is cheaper and suitable for 
the experiment. 
 
Zhernosekov et al. [34] used TLC with a 0.1 M sodium citrate solution (pH 5) as 
the mobile phase on an aluminium backed silica gel 60 support to determine the 
radiochemical purity of 68Ga-DOTATOC. The Rf of DOTATOC was 0.0 and that of 
free 68Ga3+ was 0.9. 
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2.3.2.2 HPLC Methods 
Di Pierro et al. [23] confirmed the results obtained with iTLC and Flash-TLC by 
means of an HPLC method that employed a Nucleosil C18 column (4 X 250mm) 
and a CH3CN/H20/0.1 % trifluoracetic acid (TFA) mobile phase. Zhernosekov et al 
[34] used an HPLC method with a 20 % acetonitrile/80 % trifluoroacetic acid/0.01 
% water as the mobile phase with a Machery Nagel C18 column and De Blois [33] 
et al. confirmed their iTLC-SG results by means of HPLC using a Symmetry C18 
column and 0.1 % (w/v) TFA (A) and methanol (B) mobile phases. Mukherjee et al. 
performed HPLC analysis by means of gradient elution using a C18 reversed 
phase column and water with 0.1 % TFA (solvent A) and acetonitrile with 0.1 % 
TFA (solvent B). 
 
According to the European Pharmacopoeia draft monograph [21], the method for 
the radiochemical purity determination of 68Ga-DOTATOC (edotreotide) by TLC on 
a silica gel plate uses a 77 g/L (1 M) solution of ammonium acetate in water and 
methanol (50:50 V/V) mobile phase. The monograph states that the Rf of 68Ga in 
colloidal form is 0 - 0.1 and the Rf of 68Ga-DOTATOC is 0.8-1.0. Not more than 3 
% of the total radioactivity should be due to 68Ga in colloidal form for TLC analysis. 
HPLC analysis should be performed with a mobile phase A consisting of 
TFA/water (0.1:99.9 V/V) and a mobile phase B mixture of TFA/Acetonitrile (0.1-
99.9 V/V). The retention time of 68Ga-DOTATOC is 4.2 minutes and 68GaCl3 is 0.3 
minutes. 68GaCl3 should not exceed 2 % for HPLC analysis. 
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SUMMARY AND PROBLEM STATEMENT 
From the literature review, it is clear that studies have been performed to compare 
different generator types, but no complete studies were carried out to evaluate all 
the quality parameters of the eluate over the entire life span of the generator 
(which could be for a period of 12-15 months). To determine the stability of the 
eluate it is important to determine how the yield, breakthrough, sterility and 
endotoxin levels change over the period of use. This information is vital especially 
for end users, who may not be in a position to perform these quality control tests 
and who can then be assured that the product quality remains stable. Moreover, 
the eluate is used to prepare 68Ga-DOTA peptides to be administered for clinical 
use. The radiolabelled peptides must therefore meet strict pharmaceutical 
specifications, including high radiochemical purity. It is also important to validate 
the methods used to test the 68Ga-labelled peptides to ensure that the results 
obtained are accurate and reliable. The literature is ambiguous regarding 
information provided by different TLC or iTLC methods. Although HPLC analysis is 
more accurate, iTLC is the preferred method because it is quicker and HPLC 
equipment is expensive and therefore not available in all facilities. It is however not 
clear if TLC or iTLC can be used without HPLC. 
 
The aims of this study are therefore as follows:  
Aim 1 
To evaluate the 68Ga eluate obtained from the iThemba LABS 68Ge/68Ga generator 
over a period of twelve months in order to ascertain whether the quality of the 
eluate remains stable over this time. 
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Aim 2 
To compare iTLC and TLC methods, under various conditions, and to validate the 
accuracy of iTLC against HPLC.   
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Chapter 3: Methods, Materials and Equipment 
 
This study was approved by the Stellenbosch University Research and Ethics 
committee (approval number: S15/07/143) and permission was granted for the 
experimental work to be conducted at iThemba LABS. 
 
3.1 Preparation of Solutions 
To prepare 0.6 M HCl, 30% hydrochloric acid (HCl) Suprapur (9.642 M), Merck, 
catalogue number 1.00318.0025 was used. A volume of 63.41 ml of 30% HCl was 
used to prepare 1000 ml of 0.6 M HCl in ultra-pure water. 
 
iTLC mobile phase 1: 0.1 M citrate buffer pH 5.0. Tri-sodium citrate dihydrate 
supplied by Merck, catalogue number SAAR5822500EM, was used. A mass of 
29.41 g of tri-sodium citrate dihydrate was weighed out and approximately 600 ml 
ultra-pure water was added to it. The pH of the solution was adjusted to 5.0 using 
1N hydrochloric acid (HCl) and 1N sodium hydroxide (NaOH) and ultra-pure water 
was added to make up the final volume of 1 litre. 
 
TLC mobile phase 2: 1 M ammonium acetate: methanol (1:1). A mass of  
77.08 g of ammonium acetate (Sigma-Aldrich, catalogue number 431311) was 
weighed out and diluted to 1 litre with ultra-pure water. Equal volumes of 1 M 
ammonium acetate solution and methanol (catalogue number 34860 from Sigma-
Adrich) were added together immediately before use to make a 1:1 ammonium 
acetate : methanol solution. 
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HPLC mobile phase A: 0.1% (w/v) trifluoracetic acid (TFA) solution was 
prepared using 0.67 ml of TFA Sigma-Aldrich, catalogue number 302031, per 
1000 ml of ultra-pure water. HPLC mobile phase B: Acetonitrile with catalogue 
number 34851 from Sigma-Adrich was used.  
 
To prepare tryptic soy broth (TSB), 15 g of TSB powder (Sigma-Aldrich, 
catalogue number 22092) was dissolved in 500 ml of ultra-pure water. Preparation 
instructions were obtained from the container. The solution was heated with 
stirring and then boiled for 1 minute. After transfer to suitable storage containers it 
was sterilized by autoclaving at 121 °C for 15 minutes. 
 
To prepare thioglycolate broth (TB), 14.5 g of TB (Sigma-Aldrich, catalogue 
number 70157) was dissolved in 500 ml of ultra-pure water. The solution was 
boiled until the growth media was completely dissolved. Preparation instructions 
were obtained from the container. After transfer to suitable storage containers it 
was sterilized by autoclaving at 121 °C for 15 minutes. 
 
The reagents for the endotoxin testing were prepared as per the instruction 
booklet provided with the Lonza chromogenic LAL test kit using LAL reagent water 
supplied in the kit. The Lonza LAL kit was obtained from Whitehead Scientific, 
catalogue number 50-647U. 
 
1 ppm, 5 ppm and 10 ppm ICP standard solutions of zinc, iron, tin, copper, 
aluminium, titanium, gallium and germanium were prepared using 1000 ppm 
standard solutions obtained from Industrial Analytical (catalogue numbers: zinc: 
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88118, iron: 88073, tin: 88112, copper: 88061, aluminium: 33557, titanium: 35771, 
gallium:  88066 and germanium: 88067). The 1000 ppm standard solutions were 
diluted to 100 ppm with 0.6 M HCl before being used to prepare 1 ppm, 5 ppm and 
10 ppm solutions of each metal. 
 
All solutions were used for a period of 3 months. 
 
3.2 Equipment 
Gamma spectrometer Genie 2000 
Dose calibrator Capintec CRC-55tR 
Inductively Coupled Plasma Optical 
      Emission Spectrometer (ICP-OES) Jobin Yvonn Horiba Ultima 
Radio-TLC scanner Carroll Ramsey Associates 
Incubator (32.5°) Carbolite  
Incubator (22.5°C) Labcon 
Microplate reader ELx800 
HPLC system: 
Binary HPLC Pump Perkin Elmer Series S200 
LC 
HPLC InjectorRheodyne model 7125 
HPLC column Phenomenex Luna C18 
(250 X 4.6mm), 5µm 
Integrator Shimadzu Chromatopac 
CR8A 
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Radiation flow detector Ortec NaI(Tl) detector with a 
high voltage power supply and 
rate meter 
 
3.3 Elution of the Generators 
Two 1850 MBq (50 mCi) 68Ge/68Ge generators were provided by iThemba LABS, 
South Africa. Generator 11/11/A(68Ge)_02 will be referred to as generator A and 
Generator 12/15/A(68Ge) will be referred to as generator B. The iThemba LABS 
generators were double loaded i.e. for a 1850 MBq generator 3700 MBq of Ge-68 
was loaded onto the generator column and therefore the elution efficiency was 
greater than 100% at the start of the generator life. The nominal activity was used 
to calculate the elution efficiency, i.e. elution efficiency was expressed as a 
percentage of a single loaded activity value. 
 
68Ga eluates from the iThemba LABS produced 68Ge/68Ga generator were 
monitored over a 12 month period. During this time, the generators were eluted 
daily (excluding weekends) with 5 ml of 0.6 M hydrochloric acid (HCl). Quality 
control tests were repeated on a monthly basis. The activity of 68Ga in the eluate 
was measured in the Capintec CRC-55tR Dose Calibrator. 
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3.4 Evaluation of Eluates 
3.4.1 Determination of Yield 
The elution efficiency (yield) was calculated as follows: 
 
Elution Efficiency (%) = 
68Ga activity at time of elution x 100% 
68Ge activity (nominal) on the column at the time of elution 
 
3.4.2 Determination of 68Ge Breakthrough in eluates 
After 24 hours, the eluted 68Ga has decayed, and any 68Ga present in the sample 
is only due to 68Ge breakthrough. The 68Ga present can therefore be used to 
calculate the amount of 68Ge breakthrough present in an eluate. The 68Ge 
breakthrough (radionuclidic purity) of a sample was measured at ≥ 24 hours after 
the elution of that sample using the Canberra gamma spectrometer with a 
germanium detector and Genie 2000 software. The 68Ge in the samples was 
quantified using the 511 keV peak. Counts on the gamma spectrometer were 
performed for 1000 seconds each and spectra of the eluate, standard solution and 
background were obtained. The standard solution was prepared by diluting  
1.11 MBq of 68Ge solution (prepared at iThemba LABS) to a volume of 10 ml with 
0.6 M HCl. The activity, date, time and volume were recorded on the label. The 
breakthrough was defined as the ratio of activity of 68Ge over initial 68Ga activity, 
expressed as a percentage. The 68Ge breakthrough was calculated as follows: 
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68Ge after 24 hours = 
 
(Peak Area eluate – Peak Area Bkgrd) X Activity of Std 
(Peak Area Std – Peak Area Bkgrd) 
 
Bkgrd = Background 
Std = Standard 
 
 
 
 
3.4.3 Determination of Metal Contaminants 
The metal contaminants, i.e. gallium, germanium, zinc, iron, copper, tin, titanium 
and aluminium, were determined using a Jobin Yvon Horiba Ultima inductively 
coupled plasma optical emission spectrometer (ICP-OES). Calibration curves were 
obtained over a range of 1 ppm to 10 ppm and used to determine the 
concentration of these metals in the samples. 
 
3.4.4 Sterility Testing 
Sampling for sterility testing was performed aseptically in a biohazard cabinet in a 
clean room. The sterility testing of the 68Ga eluate commenced on the day of 
elution using both tryptic soy broth (suitable for the culture of aerobic bacteria and 
fungi) and thioglycolate broth (suitable for the culture of anaerobic bacteria). In 
both instances a 5 ml volume of broth was added to 0.5 ml of 68Ga eluate. The 
sample containing tryptic soy broth was incubated at 22.5 ± 2.5°C while the 
sample containing thioglycolate broth was incubated at 32.5 ± 2.5°C [27]. An E. 
Coli positive and one negative control were incubated along with the sample for 
two weeks and checked on a daily basis for appearance of growth. The change in 
Breakthrough (%) = 
68Ge activity x 100% 
68Ga activity at the time of elution 
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appearance of the media from clear to cloudy was regarded as an indicator for 
bacterial growth. 
 
3.4.5 Endotoxin Testing 
Endotoxin testing was performed using the chromogenic method. A Lonza kit 
containing the endotoxin stock solution, LAL reagent, substrate and LAL reagent 
water was used. The endotoxin stock solution was used to prepare a set of 
endotoxin standards, ranging from 0.1 endotoxin units per millilitre (EU/ml) to 1.0 
EU/ml. The absorbance which was determined using a BioTek ELx800 plate 
reader was plotted against the concentration of the standards to create a 
calibration curve. The calibration curve was then used to determine the 
concentration of endotoxins in the eluates. The endotoxin tests were performed on 
the day of elution. The maximum dilution volume was determined to be 10 and the 
pH of samples was adjusted to within the required pH range of 6.0 – 8.0 with 1 N 
sodium hydroxide prepared with LAL reagent water.  
 
3.5 Quality Control of 68Ga-labelled peptides 
Various quality control procedures such as high performance liquid 
chromatography (HPLC) and instant thin layer chromatography (iTLC) were used 
to determine the radiochemical purity of the labelled peptides. 
 
3.5.1 HPLC 
The HPLC analysis was performed with a Phenomenex Luna C18 (250 X 4.6 mm, 
5 µm) analytical column using gradient elution with 0.1 % TFA in water (mobile 
phase A) and 100 % acetonitrile (mobile phase B) [16]. The HPLC program was as 
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follows: 0–2 min 100 % A, 2-12 min 100 % A to 30 % A and 70 % B, 12- 15 min 30 
% A and 70 % B to 100 % B, 15 -20 min 100 % B. Under these conditions the free 
68Ga eluted within a retention time range of 2.764 to 2.933 minutes.  
 
3.5.2 TLC 
Two TLC methods were investigated. Method one used 0.1 M citrate buffer, pH 5 
(mobile phase 1) as the developing mobile phase and silica gel impregnated 
instant thin layer chromatography medium (iTLC SGI0001) purchased from SMM 
Instruments as a solid support. Method 2 made use of 1 M ammonium 
acetate/methanol (1:1) as mobile phase (mobile phase 2) with either Silica Gel 60 
TLC sheets (Merck) or iTLC-SG as the stationary phase. For both methods the 
strip was 9 cm long, 1.5 cm wide and the spot with activity (185 to 370 MBq) was 
placed at 1.5 cm from the bottom of the strip. The TLC or iTLC strip was placed in 
a chromatography tank containing 10 ml of the mobile phase and allowed to 
develop until the solvent front reached a pre-marked spot, applied with a 
highlighter pen, 0.5 cm from the top of the strip. The contact of the front with this 
spot caused a blotting effect which facilitated its visualisation. Thereafter the strip 
was removed from the tank and allowed to air dry. 
The dry strips were scanned using a Carroll Ramsay Associates radio-TLC 
scanner, coupled with a Shimadzu Chromatopak CR8A. Chromatograms were 
printed out and displayed peaks with retention times (Rt) in minutes. The retention 
times were subsequently converted to the retention factor (Rf) values. The 
distance migrated was determined by multiplying the Rt obtained by the scan rate 
(2 cm/min) of the radio-TLC scanner. However, due to the geometry of the TLC 
scanner, the retention time included a dead distance (which is the distance from 
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the start of scanning to the origin of the plate or strip). The dead distance was 
always a fixed parameter and had to be determined. Therefore, activity was 
applied to the origin of a strip and scanned without developing it in the 
chromatography tank. The Rt obtained for the activity spot at the origin multiplied 
by the scan rate of the radio-TLC scanner was the dead distance. To convert the 
Rt of the developed species to distance it was multiplied by the scan rate of the 
radio-TLC scanner and the dead distance was subtracted from the result to obtain 
the real distance. Rf values were calculated by dividing this result by 7.2 cm, which 
was the distance in cm between the origin and the solvent front. See figure 2. 
 
The iTLC methods were validated by comparing their results with HPLC results 
obtained for the same sample. 
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Figure 2: Conversion of retention time (Rt) on iTLC chromatogram to 
distance. Activity was spotted at the origin and the plate was scanned without developing it in 
mobile phase. The scan rate of the radio-TLC scanner is 2 cm/min. The dead distance is the 
distance from the start of scanning to the origin = Rt at the origin X scan rate. Distance = (Rt X 
scan rate) – dead distance. 
 
  
Rt = 5.54 min (Distance = 11.08 cm) 
Rt = 1.94 min (Dead distance = 3.88 cm) 
9 cm 
Solvent Front 
Origin 
0.5 cm 
1.5 cm 
Dead distance 
Distance from origin to solvent front = 
11.08 cm – 3.88 cm = 7.2 cm 
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3.5.2.1 Determination of detectable amount of GaCl3 
iTLC was carried out on labelled peptide solutions that had been spiked with 2 % 
GaCl3. The purpose of this experiment was to verify that a clear separation 
between 68GaCl3 and 68Ga labelled peptides was obtained and that the maximum 
amount of allowable 68GaCl3 could be detected by means of iTLC. The spiked 
mixtures were prepared as follows: The activity of the purified 68Ga-DOTA peptide 
was measured in the Capintec dose calibrator and an amount of 68GaCl3 that was 
equivalent to 2 % of the total activity was added. The 68GaCl3 was measured in the 
Capintec Dose Calibrator and the time of the measurement was recorded. The 
same was done with the labelled peptide before adding the 68GaCl3. The 
measured activities were corrected for decay to determine the exact activity of the 
68GaCl3 and labelled peptide in the mixture. The mixture was spotted on iTLC 
medium and developed in mobile phase 1. The results obtained were verified by 
means of HPLC. 
 
3.5.2.2 Comparison using dried and undried iTLC paper 
iTLC strips were dried at 80 °C for 2 hours on the day of the experiments. The 
dried paper was stored in a sealed bag inside a dessicator until used. A dried and 
an undried iTLC plate were spotted with the same sample of 68Ga-DOTATATE. 
This procedure was repeated five times using different batches of 68Ga-
DOTATATE. Five experiments were also performed using 68Ga-DOTATOC and 
68Ga-DOTANOC. The iTLC plates were developed in mobile phase 1 and scanned 
on the radio-TLC scanner. After scanning, the developed strips containing free 
68GaCl3 and labelled peptide were also cut in segments of 1 cm each (measured 
from the origin) and the activity on each segment measured in a Capintec dose 
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calibrator. This showed the distribution of free 68GaCl3 and labelled peptide after 
chromatography. 
 
3.5.2.3 Colloids 
To induce the formation of colloids, the pH of the labelling mixture was adjusted to 
pH 5.0 by adding sodium acetate buffer. Samples of peptide labelled at this higher 
pH were analysed by iTLC using mobile phase 1, iTLC using mobile phase 2 and 
by means of HPLC. Radiolabelling was also performed at the normal labelling pH 
of 3.5 – 4.0 and the results were compared to those obtained at pH 5.0. With 
mobile phase 1, 68GaCl3 is expected to migrate to the solvent front while 68Ga-
labelled peptides remain at the origin. Colloids are not separated from the 68Ga-
labelled peptides with this method. With mobile phase 2, 68Ga impurities are 
expected to remain at the origin while the 68Ga-labelled peptides migrate to the 
solvent front. With the HPLC method only 68GaCl3 and 68Ga-labelled peptides are 
separated, while colloids will be retained at the beginning of the column or pre-
column. 
 
3.6 Data analysis 
To visualize the change in performance of 68Ge/68Ga generators over time the 
data collected are depicted in graphs i.e. 
• Percentage 68Ga breakthrough vs. time 
• Percentage yield vs. time 
• Concentration of metal contaminants vs. time 
• Endotoxin concentration vs. time 
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Since this data is expected to change over time, only trends were observed. All 
results were compared to pharmacopoeial limits and results obtained from two 
different generators were compared. The results from different TLC methods and 
the HPLC method used to determine radiochemical purity of the labelled product 
were compared by visual inspection. The Paired T-test was used to determine if 
there was a significant difference in the results obtained for experiments 
performed using the dried versus undried stationary phase for iTLC. 
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Chapter 4: Results 
 
4.1 Generator Eluate 
Generator A and generator B were stored in a biohazard cabinet within a clean 
room and were eluted over a period of 360 days (12 months). The generators 
were eluted manually on a daily basis and the 68Ga yield, 68Ge breakthrough, 
metal contaminants, sterility and endotoxin concentration were determined using 
the eluate that was collected every thirty days. 
 
The 68Ga yield of generator A was 132.0 % initially and gradually decreased to 
87.8 % after 12 months. The 68Ga yield of generator B was 125.0 % initially and 
progressively decreased to 85.0 % after 12 months (Figure 3). 
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Figure 3: 68Ga yields obtained for generator A and B over a 12 month period 
Eluates were measured in the Capintec dose calibrator and the measurements were used to 
calculate the yield. Measurements were done at 30 day intervals (Correlation coefficient for 
generator A was 0.7825 and for generator B was 0.938). 
 
The 68Ge breakthrough increased from 0.0003 % at the start of use to 0.1560 % 
after 12 months in generator A. The 68Ge breakthrough increased from 0.0004 % 
to 0.2672 % in generator B. A spike was observed in both generators at 300 days 
(Figure 4). This coincided with an elution after a period of 25 days during which the 
generator had not been eluted. 
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Figure 4: 68Ge breakthrough for generator A and B over a 12 month period 
The breakthrough was determined every 30 days using a gamma spectrometer at least 24 hours 
after elution. 
 
Metal contaminants were determined by means of ICP-OES every 30 days and 
are recorded in Table 3 and 4 and Figure 5. The total metal contaminants 
fluctuated slightly but Table 3 and 4 show that the average metal contaminants 
over the year remained below the pharmacopeial limit of 10 ppm throughout the 
year for both generators, except at 360 days for generator B, where it increased to 
13.48 ppm (see Table 4). The zinc concentration was 10.15 ppm and was 
probably due to a period of non-elution and the time between elution and analysis 
during which the 68Ga decayed to 68Zn. 
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TABLE 3: Metal Contaminant Data: Generator A 
ICP-OES analysis was performed on eluates from generator A at 30 day intervals. 
No. of Days 
Metal Contaminants (ppm) 
Zn Fe Cu Sn Ti Al Ge Ga 
Total  
Metals 
0 1.38 0.12 0.00 1.12 0.00 3.01 0.27 0.13 6.03 
30 1.96 0.11 0.03 0.19 0.10 0.12 0.47 0.17 3.15 
60 4.69 0.04 0.00 0.36 3.61 0.00 0.65 0.00 9.35 
90 4.42 0.25 0.01 0.98 0.08 0.98 0.46 0.15 7.33 
120 1.17 0.04 0.00 0.35 3.61 0.00 0.64 0.00 5.81 
150 0.31 0.15 0.03 0.23 0.00 1.23 0.53 0.11 2.59 
180 1.38 0.12 0.06 1.12 0.71 3.01 0.27 0.13 6.80 
210 0.35 0.12 0.03 0.18 0.10 0.15 0.43 0.18 1.54 
240 1.98 0.04 0.00 1.17 0.00 1.07 0.03 0.11 4.40 
270 0.45 0.08 0.04 0.97 0.02 1.12 0.56 0.05 3.29 
300 2.21 0.08 0.05 0.89 0.02 1.34 0.40 0.05 5.04 
330 0.46 0.08 0.04 0.97 0.02 1.12 0.56 0.05 3.30 
360 3.54 0.11 0.01 1.36 0.02 0.65 0.77 0.11 6.57 
Average 1.87 0.10 0.02 0.76 0.64 1.06 0.46 0.10 5.02 
STDEV 1.50 0.06 0.02 0.43 1.33 0.99 0.19 0.06 2.22 
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TABLE 4: Metal Contaminant Data: Generator B 
ICP-OES analysis was performed on eluates from generator B at 30 day intervals. 
No. of Days 
Metal Contaminants (ppm) 
Zn Fe Cu Sn Ti Al Ge Ga 
Total 
Metals 
0 1.93 0.07 0.02 0.22 0.01 0.29 0.21 0.75 3.50 
30 4.55 0.06 0.00 0.95 0.00 0.83 0.17 0.1 6.66 
60 4.34 0.20 0.07 0.70 0.00 0.91 0.05 0.01 6.28 
90 3.28 0.23 0.17 0.80 0.08 0.65 0.05 1.01 6.27 
120 6.62 0.17 0.07 0.81 0.00 1.08 0.04 0.02 8.81 
150 2.73 0.05 0.00 0.97 0.00 0.48 0.17 0.12 4.52 
180 3.27 0.34 0.18 1.31 0.16 0.75 0.12 0.64 6.77 
210 6.14 0.16 0.00 2.4 0.05 0.47 0.30 0.07 9.59 
240 7.56 0.18 0.07 0.93 0.00 0.81 0.04 0.01 9.60 
270 5.87 0.19 0.01 0.65 0.08 1.14 0.15 0.46 8.55 
300 2.48 0.00 0.00 1.05 0.00 0.94 0.14 0.00 4.61 
330 3.58 0.10 0.01 0.68 0.02 0.38 0.76 0.10 5.63 
360 10.15 0.42 0.38 0.31 0.40 1.01 0.41 0.40 13.48 
Average 4.81 0.17 0.08 0.91 0.06 0.75 0.20 0.28 7.25 
STDEV 2.36 0.12 0.11 0.53 0.11 0.28 0.20 0.34 2.70 
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Figure 5: Total metal contaminants for generator A and B over a 12 month 
period 
The concentration of metals in the eluates of generator A and B was determined using a Jobin 
Yvon ICP-OES at 30 day intervals. 
 
Sterility and Endotoxins 
No visible bacterial or fungal growth was seen in any of the generator eluates after 
14 days of incubation. The endotoxin concentration in the 68Ga eluates from 
generator A and B are shown in Figure 6. Endotoxin concentrations remained 
below 2 EU/ml and were within the pharmacopoeial limit of 175 EU/ml for the 
duration of the 12-month period. 
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Figure 6: Endotoxin Concentration for generator A and B over a 12 month 
period: The endotoxin concentration in the eluates of generator A and B was determined using a 
chromogenic LAL kit every 30 days. 
 
 
4.2 Analysis of 68Ga-labelled peptides 
4.2.1 HPLC Analysis 
HPLC analysis was performed on 68GaCl3 and 68Ga-DOTATATE, 68Ga-DOTATOC 
and 68Ga-DOTANOC samples with 0.1 % TFA and 100 % acetonitrile mobile 
phases. The retention time (Rt) of 68GaCl3 ranged from 2.764 minutes to 2.993 
minutes, the Rt of 68Ga-DOTATATE was between 12.077 minutes and 12.183 
minutes, 68Ga-DOTATOC was between 12.087 minutes and 12.250 minutes and 
68Ga-DOTANOC was between 12.607 minutes and 12.809 minutes (Table 5). The 
chromatograms for all the 68Ga-labelled peptides showed sharp peaks with a clear 
separation between 68GaCl3 and 68Ga-labelled peptides observed. An example of 
a typical chromatogram is shown in Figure 7. The retention times of the three 
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peptide peaks are very close to each other but this does not pose a problem 
because only one peptide is labelled at a time. 
 
TABLE 5: HPLC Retention time (Rt) of 68GaCl3, 68Ga-DOTATATE, 68Ga-
DOTATOC and 68Ga-DOTANOC 
68GaCl3 and 68Ga-DOTATATE, 68Ga-DOTATOC and 68Ga-DOTANOC were analysed by means of 
HPLC using HPLC using mobile phase A: 0.1% trifluoracetic acid (TFA) solution and mobile phase 
B: 100% acetonitrile (0–2 min 100 % A, 2-12 min 100 % A to 30 % A and 70 % B, 12- 15 min 30 % 
A and 70 % B to 100 % B, 15 -20 min 100 % B.
Exp. No. Rt 68GaCl3 
(min.) 
Rt 68Ga-’TATE 
(min.) 
Rt 68Ga-’TOC 
(min.) 
Rt 68Ga-’NOC 
(min.) 
1 2.933 12.166 12.117 12.808 
2 2.764 12.124 12.087 12.607 
3 2.917 12.183 12.217 12.737 
4 2.865 12.087 12.200 12.733 
5 2.877 12.077 12.292 12.809 
6 2.931 12.095 12.116 12.823 
7 2.941 12.098 12.250 12.763 
8 2.981 12.167 12.133 12.802 
Average 2.901 12.125 12.178 12.760 
SDEV 0.066 0.042 0.074 0.071 
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Figure 7: Typical HPLC chromatogram of 68Ga-DOTATOC before Sep-Pak 
purification 
 
4.2.2 iTLC Analysis 
4.2.2.1 iTLC analysis on undried and dried strips using mobile phase 1 (0.1 
M citrate buffer, pH 5) 
iTLC analysis was performed on 68GaCl3 and 68Ga-DOTATATE, 68Ga-DOTATOC 
and 68Ga-DOTANOC samples using undried iTLC strips, and strips that had been 
dried at 80 °C prior to use. The average retention factor (Rf) for 68GaCl3 was found 
to be 0.99 and 0.98 on undried and dried iTLC strips respectively (Table 6). The 
average Rf for 68Ga-DOTATATE was found to be 0.12 on undried iTLC strips and 
0.15 on dried iTLC strips. The average Rf of 68Ga-DOTATOC was 0.07 on undried 
iTLC strips and 0.08 on dried iTLC strips. The average Rf of 68Ga-DOTANOC was 
0.13 on undried iTLC strips and 0.10 on dried iTLC strips (Table 6). Separation 
was achieved between the 68GaCl3 peak and 68Ga-peptide peaks. An example of 
typical chromatogram is shown in Figure 8. 
 
68GaCl3 
68Ga-DOTATOC 
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TABLE 6: iTLC analysis of 68GaCl3 68Ga-DOTATATE, 68Ga-DOTATOC and 
68Ga-DOTANOC using undried and dried iTLC strips 
68GaCl3, 68Ga-DOTATATE, 68Ga-DOTATOC and 68Ga-DOTANOC were spotted on undried and 
dried iTLC strips and the strips were developed in 0.1 M citrate buffer, pH 5. The developed strips 
were scanned on a radio-TLC scanner. 
 Rf values on iTLC medium 
Exp 
No. 
68GaCl3 68Ga-
DOTATATE 
68Ga-
DOTATOC 
68Ga- 
DOTANOC 
Undried 
iTLC  
Dried 
iTLC  
Undried 
iTLC  
Dried 
iTLC  
Undried 
iTLC  
Dried 
iTLC  
Undried 
iTLC  
Dried 
iTLC  
1 0.98 0.97 0.12 0.13 0.07 0.06 0.12 0.11 
2 0.98 0.98 0.13 0.14 0.06 0.08 0.13 0.10 
3 1.00 1.00 0.11 0.16 0.08 0.09 0.13 0.10 
4 1.00 0.99 0.10 0.15 0.07 0.07 0.13 0.11 
5 0.99 0.97 0.13 0.16 0.07 0.09 0.11 0.09 
AVG 0.99 0.98 0.12 0.15 0.07 0.08 0.13 0.10 
SDEV 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
 p = 0.0993 p = 0.0285 * p = 0.2420 p = 0.0042 * 
 
 
. 
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Figure 8: Typical iTLC chromatogram of 68Ga-DOTANOC before Sep-Pak 
purification using 0.1 M citrate buffer, pH 5 
 
The following tables show the results of counting 1 cm segments of the iTLC strips 
in a dose calibrator. The activity in each segment is expressed as percentage of 
the activity on the entire strip. This experiment was only done using mobile phase 
1 (0.1 M sodium citrate). For the strips spotted with 68GaCl3, 100 % of the activity 
was found on segment 9, both on undried and dried iTLC strips. The results were 
therefore not tabulated. For the iTLC strips spotted with 68Ga-DOTATATE, 68Ga-
DOTATOC and 68Ga-DOTANOC the results show that most of the activity was in 
the first 5 segments. The data are provided in Tables 7, 8 and 9. 
  
68Ga-DOTANOC 
68GaCl3 
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TABLE 7: Percentage 68Ga-DOTATATE on dried and undried iTLC strip 
segments 
68Ga-DOTATATE was spotted on iTLC strips, developed in 0.1 M citrate buffer, pH 5 and then cut 
into 1cm segments. Each segment was measured in the Capintec dose calibrator. 
 
  
Segment 
No 
% 68Ga-DOTATE on undried iTLC Paper % 68Ga-DOTATATE on dried iTLC Paper 
Experiment number Experiment  number 
1 2 3 4 5 AVG 1 2 3 4 5 AVG 
1 
2.0 2.1 1.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.1 
2 
16.3 19.7 16.9 14.6 12.6 16.0 21.1 18.8 21.0 11.4 23.2 19.1 
3 
32.0 19.2 15.0 9.4 15.2 18.2 54.0 37.9 36.2 41.8 46.8 43.3 
4 
36.2 35.0 45.0 47.1 48.3 42.3 15.0 31.3 30.0 32.3 19.8 25.7 
5 
5.8 9.8 12.9 19.5 13.8 12.4 3.3 4.9 5.3 6.1 3.4 4.6 
6 
2.4 4.3 3.5 3.9 3.7 3.6 1.3 2.8 2.6 2.8 1.6 2.2 
7 
2.0 2.6 2.5 2.6 1.5 2.2 1.7 1.7 1.8 2.0 1.6 1.7 
8 
1.6 3.9 0.8 1.3 2.2 2.0 1.3 0.9 1.2 1.4 0.9 1.2 
9 
1.6 3.4 2.5 1.6 2.6 2.3 2.2 1.7 1.4 2.2 2.8 2.0 
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TABLE 8: Percentage 68Ga-DOTATOC on dried and undried iTLC strip 
segments 
68Ga-DOTATOC was spotted on iTLC strips, developed in 0.1 M citrate buffer, pH 5 and then cut 
into 1cm segments. Each segment was measured in the Capintec dose calibrator. 
Segment 
No 
% 68Ga-DOTATOC on undried iTLC Paper % 68Ga-DOTATOC on dried iTLC Paper 
Experiment number Experiment number 
1 2 3 4 5 AVG 1 2 3 4 5 AVG 
1 
1.7 1.0 1.2 3.1 3.0 2.0 0.6 1.3 3.1 5.1 3.3 2.7 
2 
29.9 38.4 25.7 28.6 31.1 30.7 32.6 34.0 55.9 30.1 25.4 35.6 
3 
52.7 48.2 48.2 31.9 35.3 43.2 55.5 54.2 33.5 32.6 33.6 41.9 
4 
11.1 7.6 17.4 18.0 15.6 13.9 7.2 6.6 2.9 12.1 16.2 9.0 
5 
1.2 1.5 3.4 7.6 5.6 3.8 0.9 0.9 1.1 4.5 4.9 2.5 
6 
1.0 1.0 1.7 2.3 1.9 1.6 0.5 0.6 0.9 3.0 3.9 1.8 
7 
0.8 1.0 1.2 2.3 1.9 1.4 0.5 0.9 0.5 2.7 2.8 1.5 
8 
1.2 1.0 0.5 2.5 1.7 1.4 1.1 0.9 1.1 4.7 4.1 2.4 
9 
0.5 0.5 0.7 3.9 3.9 1.9 1.1 0.9 1.1 5.1 5.9 2.8 
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TABLE 9: Percentage 68Ga-DOTANOC on dried and undried iTLC strip 
segments 
68Ga-DOTANOC was spotted on iTLC strips, developed in 0.1 M citrate buffer, pH 5 and then cut 
into 1cm segments. Each segment was measured in the Capintec dose calibrator. 
Segment 
No 
% 68Ga-DOTANOC on undried iTLC Paper % 68Ga-DOTANOC on dried iTLC Paper 
Experiment number Experiment number 
1 2 3 4 5 AVG 1 2 3 4 5 AVG 
1 
2.1 1.5 5.9 5.8 4.6 4.0 2.2 2.3 2.1 4.1 4.1 2.9 
2 
14.8 15.7 17.8 67.1 52.3 33.5 28.2 17.6 17.5 37.0 33.6 26.8 
3 
34.2 52.8 47.9 15.2 29.6 35.9 51.0 44.1 40.9 41.1 41.3 43.7 
4 
31.0 17.8 14.8 2.0 2.0 13.5 12.5 30.7 32.8 5.6 5.6 17.4 
5 
6.3 4.1 3.0 1.3 1.3 3.2 1.5 2.0 2.9 3.1 3.0 2.5 
6 
2.5 1.0 4.7 1.6 1.5 2.3 1.2 1.0 1.8 2.2 2.7 1.8 
7 
2.1 2.0 2.4 1.3 1.3 1.8 0.5 0.8 0.5 1.6 2.4 1.2 
8 
3.2 2.5 1.8 1.6 2.0 2.2 1.5 0.8 0.5 2.1 3.0 1.6 
9 
3.9 2.5 1.8 4.0 5.4 3.5 1.5 0.8 1.0 3.2 4.4 2.2 
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Figure 9: Distribution of 68Ga-DOTATATE on undried and dried iTLC paper 
 
 
 
Figure 10: Distribution of 68Ga-DOTATOC on undried and dried iTLC paper 
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Figure 11: Distribution of 68Ga-DOTANOC on undried and dried iTLC paper 
 
Figures 9, 10 and 11, show that most of the labelled peptide is distributed in 
segments 2 to 4, on both dried and undried iTLC paper. The paired-T test proved 
that the results on dried and undried iTLC paper did not differ significantly for 68Ga-
DOTATOC but a significant difference was found between the results on dried and 
undried iTLC paper for 68Ga-DOTATATE and 68Ga-DOTANOC. 
 
4.2.2.2 Determination of the detectable amount of 68GaCl3 
Purified, labelled peptides were spiked with 2 % of 68GaCl3 and the samples were 
analysed by means of both HPLC and iTLC (undried). The results obtained were 
compared. Table 10 shows that the detected amount of 68GaCl3 was found to be 
higher using HPLC than iTLC i.e. 3.44 % (HPLC) and 0.50 % (iTLC) for 68Ga-
DOTATATE, 2.85 % (HPLC) and 1.00 % (iTLC) for 68Ga-DOTATOC and 3.86 % 
(HPLC) and 0.97 % (iTLC) for 68Ga-DOTANOC. 
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TABLE 10: Radiochemical purities of 68Ga-DOTATATE, 68Ga-DOTATOC and 
68Ga-DOTANOC after Sep-Pak purification using iTLC and HPLC 
Purified 68Ga-DOTATATE, 68Ga-DOTATOC and 68Ga-DOTANOC was spiked with 2 % of 68GaCl3, 
and the radiochemical purity was determined with iTLC (using undried iTLC paper and 0.1 M citrate 
buffer, pH 5), and HPLC 
Experiment No. Peptide HPLC iTLC 
% 68GaCl3 % Peptide % 68GaCl3 % Peptide 
1 68Ga-DOTATATE 3.25 96.75 0.97 99.03 
2  3.28 96.72 0.95 99.05 
3  3.22 96.78 0.34 99.66 
4  3.63 96.37 0.22 99.78 
5  3.83 96.17 0.01 99.99 
AVG  3.44 96.56 0.50 99.50 
STDEV  0.27 0.27 0.44 0.44 
6 68Ga-DOTATOC 2.72 97.28 0.59 99.41 
7  2.56 97.44 1.42 98.58 
8  3.36 96.64 1.04 98.96 
9  3.10 96.91 1.01 98.99 
10  2.50 97.50 0.92 99.08 
AVG  2.85 97.15 1.00 99.00 
STDEV  0.37 0.37 0.30 0.30 
11 68Ga-DOTANOC 4.46 95.54 0.87 99.13 
12  4.38 95.62 0.64 99.36 
13  2.99 97.01 1.30 98.70 
15  3.20 96.80 1.08 98.92 
15  3.38 96.62 0.96 99.04 
AVG  3.68 96.32 0.97 99.03 
STDEV  0.69 0.69 0.24 0.24 
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4.2.2.3 TLC analysis using mobile phase 2 (1 M ammonium acetate: 
methanol (1:1)) 
TLC analysis was also performed on unpurified samples using mobile phase 2 (1 
M ammonium acetate: methanol (1:1)) and iTLC plates. The chromatogram, peaks 
obtained with this method were sharper than the peaks obtained using mobile 
phase 1 but the peaks overlapped slightly. The average of Rf for 68GaCl3 was 
0.15, 68Ga-DOTATATE was 0.46, 68Ga-DOTATOC was 0.52 and 68Ga-DOTANOC 
was 0.44. The results are displayed in Table 11. An example of a typical 
chromatogram is shown in Figure 12. 
 
 
TABLE 11: Retention factor (Rf) of 68GaCl3, 68Ga-DOTATATE, 68Ga-DOTATOC 
and 68Ga-DOTANOC on silica gel plates, 1 M ammonium acetate: methanol 
(1:1) mobile phase 
Retention factors (Rf) of 68GaCl3 and 68Ga-DOTATATE, 68Ga-DOTATOC and 68Ga-DOTANOC 
were determined using mobile phase 2 and the developed strips were scanned strip on a radio-
TLC scanner 
 
Exp No. 
Rf 
68Ga impurities 68Ga-DOTATATE 68Ga-DOTATOC 68Ga-DOTANOC 
1 0.14 0.47 0.53 0.44 
2 0.15 0.47 0.53 0.43 
3 0.15 0.45 0.53 0.45 
4 0.15 0.46 0.51 0.46 
5 0.14 0.46 0.51 0.42 
AVG 0.15 0.46 0.52 0.44 
SDEV 0.01 0.01 0.01 0.02 
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Figure 12: Typical iTLC chromatogram of 68Ga-DOTATATE before Sep-Pak 
purification using 1 M ammonium acetate : methanol (1:1) 
 
 
4.2.2.4 Testing for colloids 
Labelling was performed on reaction mixtures at pH 5.0 (Table 12) and 3.5 – 4.0 
(Table 13). Samples were analysed by means of HPLC and iTLC using mobile 
phase 1 and mobile phase 2. Each peptide was analysed once using each 
analytical method. An initial study with Silica gel TLC plate and mobile phase 2 did 
not separate the peaks very well (Figure 12) while iTLC gave two clearly 
separated peaks (Figure 13). 
  
68Ga-DOTATATE 
Impurities 
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TABLE 12: The radiochemical purities of 68Ga-DOTATATE, 68Ga-
DOTATOC and 68Ga-DOTANOC after Sep-Pak purification using iTLC and 
HPLC 
Radiolabelling was performed at pH 5. 
  Mobile 
phase 1 
% peptide 
Mobile 
phase 1 
% GaCl3 
Mobile 
phase 2 
%  peptide 
Mobile 
phase 2  
% impurities  
HPLC 
% 
peptide 
HPLC 
%  
GaCl3 
68Ga-
DOTATATE 
100 0 94 6 100 0 
68Ga-
DOTATOC 
100 0 88 12 100 0 
68Ga-
DOTANOC 
100 0 81 19 100 0 
 
TABLE 13: The radiochemical purities of 68Ga-DOTATATE, 68Ga-
DOTATOC and 68Ga-DOTANOC after Sep-Pak purification using iTLC and 
HPLC 
Radiolabelling was performed at pH 3.5 – 4.0. 
 
Mobile 
phase 1 
% peptide 
Mobile 
phase 1  
% GaCl3 
Mobile 
phase 2 
% peptide 
Mobile 
phase 2  
% impurities 
HPLC 
% 
peptide 
HPLC 
%  
GaCl3 
68Ga-
DOTATATE 
100 0 89 11 100.0 0 
68Ga-
DOTATOC 
100 0 94 6 100.0 0 
68Ga-
DOTANOC 
100 0 99 1 100.0 0 
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Figure 13: Typical iTLC chromatogram of 68Ga-DOTATOC after Sep-Pak 
purification using 1 M ammonium acetate : methanol (1:1) and iTLC-SG 
 
 
  
68Ga-DOTATOC 
Impurities 
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Chapter 5: Discussion and Conclusion 
 
5.1 Generator Eluate 
5.1.1 68Ga Yield 
The change in 68Ga yield with time, of the two iThemba LABS generators 
evaluated in this study, is depicted in Figure 3. The 68Ga yield decreased from 
132.0 % at the start of use to 87.8 % after 12 months (generator A) and from  
125.0 % to 85.0 % (generator B). According to Meyer et al. [35] the decrease in 
68Ga yield could be due to changes that occur in the resin which result in 68Ga 
being more tightly bound and therefore less is eluted. However, a 
pyrogallol/formaldehyde type generator and a titanium dioxide-based generator 
were used for this study. The 68Ga yield of the Obninsk 68Ge/68Ga generator is  
75 % after the first elution. A study by Asti et al. [15] demonstrated that this value 
decreased to 69 % after 7 months. The Eckert and Ziegler Galliapharm generator 
is greater than 95 %, the Galli Eo generator is 70 % – 75 % initially and decreases 
to ≥ 60 % after 12 months and the ITG generator is greater than 80 % at 
calibration time. The performance of the iThemba LABS generator remains within 
the European Pharmacopoeial limits and compares with and even exceeds that of 
some of the other generators on the market. 
 
5.1.2 68Ge Breakthrough 
The germanium breakthrough in generator A increased from 0.0003 % to 0.1560 
% and from 0.0004 % to 0.2672 % in generator B after 12 months (Figure 4). This 
study shows that the breakthrough exceeds the European Pharmacopoeial limit of 
0.001% by 120 days after start of use. A spike observed at 300 and 360 days in 
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both generators occurred after a period of non-elution of the generators due to 
public holidays. Increase in 68Ge breakthrough was also observed and reported by 
users of the iThemba LABS 68Ge/68Ga generator after periods of non-elution [J le 
Roux, personal communication Oct 2016]. Sudbrock [17] used an iThemba LABS 
generator and also demonstrated that the 68Ge breakthrough increased over time 
but even if it exceeded the European Pharmacopoeial limit of 0.001 % in the 
eluates it did not exceed it in the labelled compound because it was removed 
during the post purification step of the labelling process. M. Asti [15] evaluated a 
68Ge/68Ga generator from Cyclotron Company Obninsk over a period of 7 months. 
The 68Ge breakthrough increased by from 0.011% to 0.026%. However, after 
passing the eluate through a C-18 cartridge containing a cation exchange resin the 
68Ge breakthrough decreased by a factor of 105 in the purified eluate. Karen 
McElvany and co-workers [14] evaluated 68Ge breakthrough and elution yields of 
three different types of 68Ge/68Ga generators (alumina/EDTA, ionic alumina and tin 
dioxide) for at least one year. Results showed that the elution yields of the EDTA 
68Ge/68Ga generator dropped significantly over time while the tin dioxide generator 
provided consistently high yields of 68Ga with low 68Ge breakthrough and chemical 
impurities. 68Ge breakthrough of the iThemba LABS generator increases with time 
but this does not pose a problem in the radiolabelled product if the 68Ge is reduced 
by a purification step. The user must however be aware of the breakthrough 
because it poses a waste problem. According to the United States Nuclear 
Regulatory Commission, the release of 68Ge to sewers is limited to 6.00 x 10-4 
µCi/ml (22.2 Bq/ml) (monthly average concentration) [37]. Regulations may differ 
from country to country. It is clear that waste from generator elution or 68Ga 
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labelling procedures cannot be discarded immediately. The user must have the 
facility to store the waste until it has decayed to acceptable levels. 
 
5.1.3 Metal Contaminants 
Eight metals were tested for (Zn, Fe, Al, Sn, Ge, Ga, Ti and Cu) and the total 
metal contaminants generally remained below 10 ppm (5.41µg/GBq for a 50 mCi 
generator). The results are shown in Table 3 and Table 4 and Figure 5. The only 
exception occurred in Generator B at 360 days, where the total metal content was 
13.48 ppm. The high zinc concentration (10.15 ppm) contributed to the much 
higher total. Zinc ions will always be present in the eluate of 68Ge/68Ga generators 
because 68Ga decays to 68Zn. A period of non-elution would lead to more in-
growth of 68Zn in the generator [3], which would contribute to an increase in 68Zn in 
the eluate. Therefore, the amount of zinc in the eluate depends on the time 
between elutions. Zinc content can be minimised by eluting the generator daily. 
Zn3+ and Fe3+ compete with Ga3+ during the labelling process and must therefore 
be minimal. 
 
If the breakthrough and metal contaminants in the eluate exceed the required 
limits (> 0.001 % for 68Ge breakthrough and 10 µg/GBq Fe and Zn individually), 
then the quality of the generator eluate can be improved by means of either 
fractionation, cation exchange or anion exchange chromatography [36]. In the 
fractionation method the activity would be concentrated in a smaller volume and 
therefore metal contaminants would be less. In a study performed by Asti et al. the 
zinc content of eluates was approximately 102 µg/L and iron 103 µg/L. After 
passing the eluate through a C-18 cartridge containing a cation exchange resin 
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there was a 95% reduction in metal contaminants including zinc and iron. The 
68Ge breakthrough decreased by a factor of 105 in the purified eluate [15]. 
 
5.1.4 Sterility and Endotoxins 
Sterility: No visible bacterial or fungal growth was detected in any of the eluates 
after 14 days of incubation using both tryptic soy broth and thioglycolate broth. The 
microbiological tests in this study have therefore shown that the generator eluate 
remains sterile for a period of 1 year in the case of both generators. This confirms 
what Petrik et al. [20] stated i.e. the 68Ge/68Ga generator eluate is not conducive to 
the growth of microorganisms including Helicobactor pylori (which proliferates in 
very acidic medium) and Deinococcus radiodurans (which is able to proliferate in a 
radioactive medium). 
Endotoxins: Endotoxin levels remained below 2 EU/ml. This is within the 
European Pharmacopoeial limit of 175 EU/V. See figure 6. 
 
5.2 Analysis of 68Ga-labelled peptides 
From table 5, the average HPLC Rt of 68GaCl3 was 2.901 minutes, the average Rt 
of 68Ga-DOTATATE was 12.125 minutes, the average retention time of 68Ga-
DOTATOC was 12.178 minutes and the average Rt of 68Ga-DOTANOC was 
12.760 minutes. Clear separation was obtained between 68GaCl3 and 68Ga-
labelled peptides. The retention times of the peptides are very close together but 
this does not pose a problem because only one peptide is labelled at a time. The 
small difference in retention times of the labelled peptides is probably due to the 
similarity in the molecular structure. 
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In a comparison of dried versus undried iTLC strips, significant differences were 
found in the case of 68Ga-DOTATATE and 68Ga-DOTANOC. However, the peaks 
of these peptides and 68GaCl3 could be clearly separated. Despite the statistically 
significant difference, in practice either undried or dried iTLC may be used. 
 
The iTLC retention factor (Rf) data for free 68Ga, as well as for the labelled 
peptides, are given in Table 6 and are fairly consistent. For the sake of institutions 
lacking instrumentation such as a TLC scanner, data were also presented where 
developed plates were cut in segments and the activity of each segment was 
determined (see Tables 7, 8 and 9). The results were also graphically represented 
in Figures 9, 10 and 11. The data shows the distribution of free 68GaCl3 and 
labelled peptide after chromatography and also show a clear separation between 
free 68Ga and labelled peptide (see Figure 8). The major part of the activity, 
associated with the labelled peptides (average 95 - 97 %), is concentrated in the 
segments 1 to 7, while about 3 – 5 % of the radioactivity, corresponding to free 
68Ga, is concentrated in segments 8 to 9. The percentage of 68Ga-labelled peptide 
peaks determined by radio-TLC scanner was found to be 96 – 99 %. This ‘cut and 
count’ method could therefore be used to determine Rf if a TLC scanner is not 
available. Using the strips described in our work, the strips can probably be cut at 
7 cm from the bottom of the strip. The bottom section would represent the labelled 
peptide and the top section the free 68GaCl3. 
 
Table 10 shows results for iTLC analysis performed using each of the three radio-
labelled peptides spiked with 2 % 68GaCl3. Clear separation of 68GaCl3 from 
labelled peptide using different amounts will demonstrate the sensitivity of the 
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method. If similar results are obtained using HPLC, then the iTLC method which is 
quicker than the HPLC method can be used in instances where there is a time 
constraint or if no HPLC is available. The percentage of 68GaCl3 obtained using 
HPLC was always higher than 2 % while the percentage of 68GaCl3 obtained for 
the same sample using iTLC was always found to be less than 2 %. It is safer to 
use the HPLC method which overestimates the actual result than a method that 
underestimates the impurity. 
 
The results in Table 11 show the Rf values obtained for 68GaCl3, 68Ga-
DOTATATE, 68Ga-DOTATOC and 68Ga-DOTANOC using mobile phase 2. 
Although sharp peaks were achieved with this method, a slight overlap of peaks 
occurred between 68GaCl3 and 68Ga-peptides. An example of a chromatogram is 
displayed in Figure 12. This method was performed on a TLC plate and was 
developed for 30 minutes as opposed to the iTLC method (mobile phase 1) in 
which the strip was developed for 3.5 minutes. When iTLC was performed with 
mobile phase 2 on iTLC paper the development time was approximately 10 
minutes and clear separation was obtained between peaks. It is therefore 
recommended that iTLC paper be used with mobile phase 2 instead of silica gel 
plates. According to Mukherjee [32], the ammonium acetate/methanol mixture on 
paper was able to separate colloidal gallium from labelled peptides. Our study with 
peptides labelled at higher pH to induce colloid formation (Tables 12 and 13) 
confirmed that iTLC-SG with mobile phase 2 is also suitable to distinguish 
between colloidal 68Ga and 68Ga-labelled peptides. In contrast, iTLC using mobile 
phase 1 and HPLC showed a higher radiochemical purity because colloids cannot 
be separated from the 68Ga-labelled peptides with these methods. It is interesting 
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to note that the Sep-Pak C-18 cartridge did not remove all impurities formed at a 
higher pH. We have no explanation for the high level of impurities formed in 68Ga-
DOTATATE at pH 3.5 – 4.0.  
 
Weaknesses of this study 
 Ideally, more generators should have been evaluated. However, only one 
generator was available per year because customer requirements were 
also considered. 
 Further experiments should be performed to determine the lower limit of 
68Ga that can be detected using the iTLC method. 
 No clear separation was obtained between 68GaCl3 and 68Ga-labelled 
peptides when using mobile phase 2 and TLC plates. This aspect should be 
investigated further. More experiments with mobile phase 2 and iTLC-SG 
strips should also be done to confirm the findings of the limited work done in 
this study. 
 
Strengths of this study 
 Other studies have been performed to evaluate the iThemba LABS 
generator but none of them was as comprehensive as the current work. In 
the study performed by McElvany et al. [14] the 68Ge breakthrough and 
metal contaminants were compared over a period of 1 year but the 
generator was eluted with 1 M HCl instead of 0.6 M HCl as recommended 
by the manufacturer. Das et al. [16] performed an evaluation of a tin dioxide 
generator over a period of six months. Random eluates were used to 
monitor elution efficiency, 68Ge breakthrough and 65Zn content. Sudbrock et 
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al. [17] used four iThemba LABS generators to evaluate the 68Ge 
breakthrough over time. Three of the generators were evaluated over a 
period of nine months while the fourth generator was evaluated over a 
period of eight months. 68Ge breakthrough was determined on 123 eluates 
and 115 68Ga-DOTATATE samples. In our study a comprehensive 
evaluation which included 68Ga yield, 68Ge breakthrough, metal 
contaminants, endotoxins, sterility and samples were analysed on a 
monthly basis over a one year period. 
 
Recommendations for the user 
Generator 
There are differences between generators from different manufacturers and this 
will affect aspects of use including the eluents, impurities, purification methods, 
labelling methods, safety and waste disposal. 
The generator should be eluted daily to avoid increased 68Ge and zinc ions in the 
eluate. If the generator has not been eluted daily, then it should be eluted at least 
once before the eluate is used for radio-labelling. 
Some form of purification of the eluate or fractional elution is recommended for the 
iThemba Labs generator. 
Users should also be aware of the 68Ge breakthrough especially with regards to 
waste disposal. 
 
Chromatography 
Either dried or undried iTLC strips can be used. 
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In cases where a radio-TLC scanner is not available, strips can be cut in two 
segments and the activity on each strip can be determined using a dose calibrator. 
For the 9 cm strips in this work, cutting at 7 cm from the bottom of the strip would 
be appropriate. 
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Conclusion 
This study demonstrates that the iThemba LABS 68Ge/68Ga generator remains 
stable over a period of at least one year with the yield, metal contaminants, sterility 
and endotoxin concentration still within the European Pharmacopoeial limits. The 
breakthrough increases to above the specification but can be reduced by 
fractionated elution or by using anion and/or cation exchange chromatography. 
However, to obtain consistent, reliable results the generator must be eluted daily 
or at least a few times before labelling if there has been a period of non-elution. 
Even though the very acidic environment of the generator is not conducive to the 
growth of microorganisms, the generator should be stored and eluted in a 
biohazard cabinet in a clean room to ensure the sterility of the eluate. The eluate 
can be used for a period of up to one year but by that time the amount of 68Ga 
eluted will be very low (less than 185 MBq for a 1850 MBq generator). Using it will 
therefore depend on the amount of 68Ga activity required. 
 
Clear separation was obtained for 68GaCl3 and 68Ga-lablled peptides using both 
iTLC with citrate buffer and HPLC, but the HPLC method proved to be more 
reliable for the determination of 68GaCl3 in 68Ga-DOTA peptides. It was 
demonstrated that the iTLC strips could be cut into segments and the segments 
measured on a dose calibrator for situations where there is no HPLC or TLC 
scanner available. The results also show that it is recommended but not essential 
to use dried chromatography paper for iTLC. The iTLC method using ammonium 
acetate/methanol seems to be the optimal system for routine analysis of 68Ga 
labelled DOTA-peptides, as it separates both 68GaCl3 and colloidal impurities from 
the labelled peptides and is a fast and easy technique. 
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